205 related articles for article (PubMed ID: 32041354)
1. Host-Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity.
Tromp AT; Van Gent M; Jansen JP; Scheepmaker LM; Velthuizen A; De Haas CJC; Van Kessel KPM; Bardoel BW; Boettcher M; McManus MT; Van Strijp JAG; Lebbink RJ; Haas PA; Spaan AN
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32041354
[TBL] [Abstract][Full Text] [Related]
2. Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.
Tromp AT; Van Gent M; Abrial P; Martin A; Jansen JP; De Haas CJC; Van Kessel KPM; Bardoel BW; Kruse E; Bourdonnay E; Boettcher M; McManus MT; Day CJ; Jennings MP; Lina G; Vandenesch F; Van Strijp JAG; Lebbink RJ; Haas PA; Henry T; Spaan AN
Nat Microbiol; 2018 Jun; 3(6):708-717. PubMed ID: 29736038
[TBL] [Abstract][Full Text] [Related]
3. Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
Spaan AN; Schiepers A; de Haas CJ; van Hooijdonk DD; Badiou C; Contamin H; Vandenesch F; Lina G; Gerard NP; Gerard C; van Kessel KP; Henry T; van Strijp JA
J Immunol; 2015 Aug; 195(3):1034-43. PubMed ID: 26091719
[TBL] [Abstract][Full Text] [Related]
4. TPST2-mediated receptor tyrosine sulfation enhances leukocidin cytotoxicity and
He J; Yang X; Yang K; Xu H; Chen C; Wang J; Zeng J
Front Immunol; 2023; 14():1242330. PubMed ID: 37671153
[TBL] [Abstract][Full Text] [Related]
5. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.
Spaan AN; Henry T; van Rooijen WJM; Perret M; Badiou C; Aerts PC; Kemmink J; de Haas CJC; van Kessel KPM; Vandenesch F; Lina G; van Strijp JAG
Cell Host Microbe; 2013 May; 13(5):584-594. PubMed ID: 23684309
[TBL] [Abstract][Full Text] [Related]
6. Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.
Reyes-Robles T; Lubkin A; Alonzo F; Lacy DB; Torres VJ
EMBO Rep; 2016 Mar; 17(3):428-40. PubMed ID: 26882549
[TBL] [Abstract][Full Text] [Related]
7. The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors.
Spaan AN; Vrieling M; Wallet P; Badiou C; Reyes-Robles T; Ohneck EA; Benito Y; de Haas CJ; Day CJ; Jennings MP; Lina G; Vandenesch F; van Kessel KP; Torres VJ; van Strijp JA; Henry T
Nat Commun; 2014 Nov; 5():5438. PubMed ID: 25384670
[TBL] [Abstract][Full Text] [Related]
8. Pathological profiles of systemic infections by Panton-Valentine leukocidin-positive, methicillin-resistant Staphylococcus aureus strains in a murine model.
Silva-Santana G; Aguiar-Alves F; Lenzi-Almeida KC; Lopes VGS; Silva LE; Hirata Júnior R; Viana VG; Simpson-Lourêdo L; Escaleira ACN; Gerth JC; Almosny NRP; Souza AM; Mattos-Guaraldi AL
J Appl Microbiol; 2020 Jun; 128(6):1820-1842. PubMed ID: 31999872
[TBL] [Abstract][Full Text] [Related]
9. Unlatching of the stem domains in the Staphylococcus aureus pore-forming leukocidin LukAB influences toxin oligomerization.
Ilmain JK; Perelman SS; Panepinto MC; Irnov I; Coudray N; Samhadaneh N; Pironti A; Ueberheide B; Ekiert DC; Bhabha G; Torres VJ
J Biol Chem; 2023 Dec; 299(12):105321. PubMed ID: 37802313
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus Coordinates Leukocidin Expression and Pathogenesis by Sensing Metabolic Fluxes via RpiRc.
Balasubramanian D; Ohneck EA; Chapman J; Weiss A; Kim MK; Reyes-Robles T; Zhong J; Shaw LN; Lun DS; Ueberheide B; Shopsin B; Torres VJ
mBio; 2016 Jun; 7(3):. PubMed ID: 27329753
[TBL] [Abstract][Full Text] [Related]
11.
Berends ETM; Zheng X; Zwack EE; Ménager MM; Cammer M; Shopsin B; Torres VJ
mBio; 2019 Jan; 10(1):. PubMed ID: 30602580
[No Abstract] [Full Text] [Related]
12. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
13. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus.
Cardot-Martin E; Casalegno JS; Badiou C; Dauwalder O; Keller D; Prévost G; Rieg S; Kern WV; Cuerq C; Etienne J; Vandenesch F; Lina G; Dumitrescu O
Lett Appl Microbiol; 2015 Aug; 61(2):158-64. PubMed ID: 25963798
[TBL] [Abstract][Full Text] [Related]
14. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics.
Badarau A; Trstenjak N; Nagy E
Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice.
Lubkin A; Lee WL; Alonzo F; Wang C; Aligo J; Keller M; Girgis NM; Reyes-Robles T; Chan R; O'Malley A; Buckley P; Vozhilla N; Vasquez MT; Su J; Sugiyama M; Yeung ST; Coffre M; Bajwa S; Chen E; Martin P; Kim SY; Loomis C; Worthen GS; Shopsin B; Khanna KM; Weinstock D; Lynch AS; Koralov SB; Loke P; Cadwell K; Torres VJ
Cell Host Microbe; 2019 Mar; 25(3):463-470.e9. PubMed ID: 30799265
[TBL] [Abstract][Full Text] [Related]
16. Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus.
Koop G; Vrieling M; Storisteanu DM; Lok LS; Monie T; van Wigcheren G; Raisen C; Ba X; Gleadall N; Hadjirin N; Timmerman AJ; Wagenaar JA; Klunder HM; Fitzgerald JR; Zadoks R; Paterson GK; Torres C; Waller AS; Loeffler A; Loncaric I; Hoet AE; Bergström K; De Martino L; Pomba C; de Lencastre H; Ben Slama K; Gharsa H; Richardson EJ; Chilvers ER; de Haas C; van Kessel K; van Strijp JA; Harrison EM; Holmes MA
Sci Rep; 2017 Jan; 7():40660. PubMed ID: 28106142
[TBL] [Abstract][Full Text] [Related]
17. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
[TBL] [Abstract][Full Text] [Related]
19. Targeting NLRP3 and Staphylococcal pore-forming toxin receptors in human-induced pluripotent stem cell-derived macrophages.
Chow SH; Deo P; Yeung ATY; Kostoulias XP; Jeon Y; Gao ML; Seidi A; Olivier FAB; Sridhar S; Nethercott C; Cameron D; Robertson AAB; Robert R; Mackay CR; Traven A; Jin ZB; Hale C; Dougan G; Peleg AY; Naderer T
J Leukoc Biol; 2020 Sep; 108(3):967-981. PubMed ID: 32531864
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
Seilie ES; Bubeck Wardenburg J
Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
